Chronix Biomedical GmbH

Industry / private company


Location: Göttingen, Germany (DE) DE

ISNI: -

Association of Blood Donor-derived Cell-free DNA Levels with Banff Scores and Histopathological Lesions in Kidney Allograft Biopsies: Results from an Observational Study (2025) Akifova A, Budde K, Choi M, Amann KU, Büttner-Herold M, Oellerich M, Beck J, et al. Journal article Donor-Derived Cell-Free DNA as a Companion Biomarker for AMR Treatment With Daratumumab: Case Series (2024) Osmanodja B, Akifova A, Budde K, Oellerich M, Beck J, Bornemann-Kolatzki K, Schütz E, et al. Journal article Comparative RNA-Seq of nine canine cell lines derived from prostate adenocarcinoma (PAC), PAC metastasis and transitional cell carcinoma (TCC) (2022) Packeiser E, Taher L, Ernst M, Beck J, Hewicker-Trautwein M, Brenig B, Schuetz E, et al. Conference contribution RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures (2022) Packeiser EM, Taher L, Kong W, Ernst M, Beck J, Hewicker-Trautwein M, Brenig B, et al. Journal article Suitability of ultrasound-guided fine-needle aspiration biopsy for transcriptome sequencing of the canine prostate (2019) Thiemeyer H, Taher L, Schille JT, Harder L, Hungerbuehler SO, Mischke R, Hewicker-Trautwein M, et al. Journal article Combined inhibition of BTK and PI3K acts synergistically in a canine B-cell lymphoma in vitro model (2019) Kong W, Sender S, Sekora A, Ma Y, Ruetgen B, Nolte I, Taher L, et al. Conference contribution